Murine Bone Marrow Mesenchymal Stromal Cells Respond Efficiently to Oxidative Stress Despite the Low Level of Heme Oxygenases 1 and 2

Antioxidants and Redox Signaling

Volumn 29, Issue 2, 2018, Pages 111-127

  Nowak, Witold Norbert ^a   Taha, Hevidar ^a,b   Kachamakova Trojanowska, Neli ^a   Stȩpniewski, Jacek ^a   Markiewicz, Joanna Agata ^a   Kusienicka, Anna ^a   Szade, Krzysztof ^a   Szade, Agata ^a   Bukowska Strakova, Karolina ^a,c   Hajduk, Karolina ^a   Klóska, Damian ^a   Kopacz, Aleksandra ^a   Grochot Przȩczek, Anna ^a   Barthenheier, Kathrin ^a   Cauvin, Camille ^a   Dulak, Józef ^a,d   Józkowicz, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF DUHOK   (Iraq)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d Silesia Medical School   (Poland)

Author keywords

Antioxidant gene response; Heme; Mesenchymal stem cell; Stem cells

Indexed keywords

CYTOKINE; GLUCOSE; GROWTH FACTOR; HEME OXYGENASE 1; HEME OXYGENASE 2; HEMIN; ANTIOXIDANT; HEME OXYGENASE; HEME OXYGENASE-2; HMOX1 PROTEIN, MOUSE; HYDROGEN PEROXIDE; MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW STROMA CELL; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MESENCHYMAL STEM CELL; METABOLISM;

ANIMALS; ANTIOXIDANTS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINES; FIBROBLASTS; GENE EXPRESSION; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HEMIN; HYDROGEN PEROXIDE; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PHENOTYPE;

EID: 85048598242     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2017.7097     Document Type: Article

References (69)

1. Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, Cai T, Chen W, Sun L, and Shi S. Mesenchymal-stemcell-induced immunoregulation involves FAS-ligand-/FASmediated T cell apoptosis. Cell Stem Cell 10: 544-555, 2012.
2. Ankrum JA, Ong JF, and Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32: 252-260, 2014.
3. Barbagallo I, Vanella A, Peterson SJ, Kim DH, Tibullo D, Giallongo C, Vanella L, Parrinello N, Palumbo GA, Di Raimondo F, Abraham NG, and Asprinio D. Overexpression of heme oxygenase-1 increases human osteo-blast stem cell differentiation. J Bone Miner Metab 28: 276-288, 2009.
4. Benzie IF and Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 299: 15-27, 1999.
5. Bianco P. ''Mesenchymal'' stem cells. Annu Rev Cell Dev Biol 30: 677-704, 2014.
6. Caplan AI. Mesenchymal stem cells. J Orthop Res 9: 641-650, 1991.
7. Chabannes D, Hill M, Merieau E, Rossignol J, Brion R, Soulillou JP, Anegon I, and Cuturi MC. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110: 3691-3694, 2007.
8. Ding L, Saunders TL, Enikolopov G, and Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481: 457-462, 2012.
9. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, and Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317, 2006.
10. Dulak J, Deshane J, Jozkowicz A, and Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117: 231-241, 2008.
11. Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, Baan CC, Dahlke MH, and Hoogduijn MJ. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol 3: 297, 2012.
12. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37: 277-285, 2004.
13. Fisher AB. Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. Antioxid Redox Signal 15: 831-844, 2011.
14. Florczyk U, Jazwa A, Maleszewska M, Mendel M, Szade K, Kozakowska M, Grochot-Przeczek A, Viscardi M, Czauderna S, Bukowska-Strakova K, Kotlinowski J, Jozkowicz A, Loboda A, and Dulak J. Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrowderived proangiogenic cells and hind limb ischemia. Antioxid Redox Signal 20: 1693-1708, 2014.
15. Foresti R, Hoque M, Bains S, Green CJ, and Motterlini R. Haem and nitric oxide: synergism in the modulation of the endothelial haem oxygenase-1 pathway. Biochem J 372(Pt 2): 381-390, 2003.
16. Grochot-Przeczek A, Kotlinowski J, Kozakowska M, Starowicz K, Jagodzinska J, Stachurska A, Volger OL, Bukowska-Strakova K, Florzyk U, Tertil M, Jazwa A, Szade K, Stepniewski J, Loboda A, Horrevoets AJ, Dulak J, and Jozkowicz A. Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization. Antioxid Redox Signal 20: 1677-1692, 2014.
17. Grundemar L and Ny L. Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci 18: 193-195, 1997.
18. Hamedi-Asl P, Halabian R, Bahmani P, Mohammadipour M, Mohammadzadeh M, Roushandeh AM, Jahanian-Najafabadi A, Kuwahara Y, and Roudkenar MH. Adenovirusmediated expression of the HO-1 protein within MSCs decreased cytotoxicity and inhibited apoptosis induced by oxidative stresses. Cell Stress Chaperones 17: 181-190, 2011.
19. Ho P-J, Yen M-L, Tang B-C, Chen C-T, and Yen BL. H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells. Antioxid Redox Signal 18: 1895-1905, 2013.
20. Hou C, Shen L, Huang Q, Mi J, Wu Y, Yang M, Zeng W, Li L, Chen W, and Zhu C. The effect of heme oxygenase-1 complexed with collagen on MSC performance in the treatment of diabetic ischemic ulcer. Biomaterials 34: 112-120, 2013.
21. Jain A, Lamark T, Sjrttem E, Larsen KB, Awuh JA, \Overvatn A, McMahon M, Hayes JD, and Johansen T. P62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285: 22576-22591, 2010.
22. Jaishankar A, Barthelery M, Freeman WM, Salli U, Ritty TM, and Vrana KE. Human embryonic and mesenchymal stem cells express different nuclear proteomes. Stem Cells Dev 18: 793-802, 2009.
23. Jozkowicz A and Dulak J. Effects of protoporphyrins on production of nitric oxide and expression of vascular endothelial growth factor in vascular smooth muscle cells and macrophages. Acta Biochim Pol 50: 69-79, 2003.
24. Kasper G, Mao L, Geissler S, Draycheva A, Trippens J, Kühnisch J, Tschirschmann M, Kaspar K, Perka C, Duda GN, and Klose J. Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells 27: 1288-1297, 2009.
25. Kim KB, Chae YC, Han A, Kang JY, Jung H, Park JW, Hahm JY, Kim S, and Seo SB. Negative regulation of peroxiredoxin 6 (Prdx 6) transcription by nuclear oncoprotein DEK during leukemia cell differentiation. Anim Cells Syst 18: 318-323, 2014.
26. Kim YJ, Hwang SJ, Bae YC, and Jung JS. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27: 3093-3102, 2009.
27. Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa A, Grochot-Przeczek A, Kotlinowski J, Szymula A, Bartelik A, Mazam M, Yagensky O, Florczyk U, Lemke K, Zebzda A, Dyduch G, Nowak W, Szade K, Stepniewski J, Majka M, Derlacz R, Loboda A, Dulak J, and Jozkowicz A. Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. Antioxid Redox Signal 16: 113-127, 2012.
28. Kumar S and Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett 157: 175-188, 2005.
29. Laird MD, Wakade C, Alleyne CH Jr, and Dhandapani KM. Hemin-induced necroptosis involves glutathione depletion in mouse astrocytes. Free Radic Biol Med 45: 1103-1114, 2008.
30. Lee CH, Shah B, Moioli EK, and Mao JJ. CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest 120: 3340-3349, 2010.
31. Lin CY, Peng CY, Huang TT, Wu ML, Lai YL, Peng DH, Chen PF, Chen HF, Yen BL, Wu KK, and Yet SF. Exacerbation of oxidative stress-induced cell death and differentiation in induced pluripotent stem cells lacking heme oxygenase-1. Stem Cells Dev 21: 1675-1687, 2012.
32. Lin TH, Tang CH, Hung SY, Liu SH, Lin YM, Fu WM, and Yang RS. Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. J Cell Physiol 222: 757-768, 2010.
33. Mabuchi Y, Morikawa S, Harada S, Niibe K, Suzuki S, Renault-Mihara F, Houlihan DD, Akazawa C, Okano H, and Matsuzaki Y. LNGFR(+)THY-1(+)VCAM-1(hi+) cells reveal functionally distinct subpopulations in mesenchymal stem cells, Stem Cell Reports 1: 152-165, 2013.
34. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, and Frenette PS. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834, 2010.
35. Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, and Banerjee D. Carcinomaassociated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339, 2008.
36. Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, Suzuki S, Miyauchi-Hara C, Nagoshi N, Sunabori T, Shimmura S, Miyawaki A, Nakagawa T, Suda T, Okano H, and Matsuzaki Y. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 206: 2483-2496, 2009.
37. Mougiakakos D, Jitschin R, Johansson CC, Okita R, Kiessling R, and Le Blanc K. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117: 4826-4835, 2011.
38. Munakata H. Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. J Biochem 136: 233-238, 2004.
39. Nauta AJ and Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506, 2007.
40. Nowak WN, Borys S, Kusinska K, Bukowska-Strakova K, Witek P, Koblik T, Jozkowicz A, Malecki MT, and Dulak J. Number of circulating pro-angiogenic cells, growth factor and anti-oxidative gene profiles might be altered in type 2 diabetes with and without diabetic foot syndrome. J Diabetes Investig 5: 99-107, 2014.
41. Omatsu Y, Sugiyama T, Kohara H, Kondoh G, Fujii N, Kohno K, and Nagasawa T. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33: 387-399, 2010.
42. Poss KD and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94: 10919-10924, 1997.
43. Puri N, Sodhi K, Haarstad M, Kim DH, Bohinc S, Foglio E, Favero G, and Abraham NG. Heme induced oxidative stress attenuates sirtuin1 and enhances adipogenesis in mesenchymal stem cells and mouse pre-adipocytes. J Cell Biochem 113: 1926-1935, 2012.
44. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliagico E, Ferrari S, Robey PG, Riminucci M, and Bianco P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336, 2007.
45. Schmid I, Uittenbogaart C, and Jamieson BD. Live-cell assay for detection of apoptosis by dual-laser flow cytometry using Hoechst 33342 and 7-amino-actinomycin D. Nat Protoc 2: 187-190, 2007.
46. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, and Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA 106: 5171-5176, 2009.
47. Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-Saadatmandi C, Rimbach G, Jozkowicz A, Dulak J, and Loboda A. Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol Nutr Food Res 57: 504-515, 2012.
48. Starzynski RR, Canonne Hergaux F, Lenartowicz M, Krzeptowski W, Willemetz A, Stys A, Bierla J, Pietrzak P, Dziaman T, and Lipinski P. Ferroportin expression in haem oxygenase 1-deficient mice. Biochem J 449: 69-78, 2012.
49. Stepniewski J, Kachamakova-Trojanowska N, Ogrocki D, Szopa M, Matlok M, Beilharz M, Dyduch G, Malecki MT, Jozkowicz A, and Dulak J. Induced pluripotent stem cells as a model for diabetes investigation. Sci Rep 5: 8597, 2015.
50. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
51. Su J, Chen X, Huang Y, Li W, Li J, Cao K, Cao G, Zhang L, Li F, Roberts AI, Kang H, Yu P, Ren G, Ji W, Wang Y, and Shi Y. Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species 21: 388-396, 2013.
52. Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, and Igarashi K. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J 21: 5216-5224, 2002.
53. Taha H, Skrzypek K, Guevara I, Nigisch A, Mustafa S, Grochot-Przeczek A, Ferdek P, Was H, Kotlinoski J, Kozakowska M, Balcerczyk A, Muchova L, Vitek L, Weigel G, Dulak J, and Jozkowicz A. Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol 30: 1634-1641, 2010.
54. Tsubokawa T, Yagi K, Nakanishi C, Zuka M, Nohara A, Ino H, Fujino N, Konno T, Kawashiri MA, Ishibashi-Ueda H, Nagaya N, and Yamagishi M. Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am J Physiol Heart Circ Physiol 298: H1320-H1329, 2010.
55. Valle-Prieto A and Conget PA. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev 19: 1885-1893, 2010.
56. Vanella L, Kim DH, Asprinio D, Peterson SJ, Barbagallo I, Vanella A, Goldstein D, Ikehara S, Kappas A, and Abraham NG. HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Bone 46: 236-243, 2010.
57. Vanella L, Kim DH, Sodhi K, Barbagallo I, Burgess AP, Faick JR, Schwartzman ML, and Abraham NG. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid Mediat 96: 54-62, 2011.
58. Vanella L, Sanford C, Kim DH, Abraham NG, and Ebraheim N. Oxidative stress and heme oxygenase-1 regulated human mesenchymal stem cells differentiation. Int J Hypertens 2012: 1-10, 2012.
59. Vanella L, Sodhi K, Kim DH, Puri N, Maheshwari M, Hinds TD, Bellner L, Goldstein D, Peterson SJ, Shapiro JI, and Abraham NG. Increased heme-oxygenase 1 expression decreases adipocyte differentiation and lipid accumulation in mesenchymal stem cells via upregulation of the canonical Wnt signaling cascade. Stem Cell Res Ther 4: 28, 2013.
60. Wagner W, Feldmann RE Jr., Seckinger A, Maurer MH, Wein F, Blake J, Krause U, Kalenka A, Bü rgers HF, Saffrich R, Wuchter P, Kuschinsky W, and Ho AD. The heterogeneity of human mesenchymal stem cell preparations-evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol 34: 536-548, 2006.
61. Warnatz HJ, Schmidt D, Manke T, Piccini I, Sultan M, Borodina T, Balzereit D, Wruck W, Soldatov A, Vingron M, Lehrach H, and Yaspo ML. The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle. J Biol Chem 286: 23521-23532, 2011.
62. Was H, Sokolowska M, Sierpniowska A, Dominik P, Skrzypek K, Lackowska B, Pratnicki A, Grochot-Przeczek A, Taha H, Kotlinowski J, Kozakowska M, Mazan A, Nowak W, Muchova L, Vitek L, Ratajska A, Dulak J, and Jozkowicz A. Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice. Free Radic Biol Med 51: 1717-1726, 2011.
63. Wojakowski W, Tendera M, Cybulski W, Zuba-Surma EK, Szade K, Florczyk U, Kozakowska M, Szymula A, Krzych L, Paslawska U, Paslawski R, Milewski K, Buszman P, Nabialek E, Kuczmik W, Janiszewski A, Dziexgiel P, Buszman PE, Jozkowicz A, and Wojakowski W. Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury. Thromb Haemost 108: 464-475, 2012.
64. This reference has been deleted.
65. Zarjou A, Jeney V, Arosio P, Poli M, Antal-Szalmas P, Agarwal A, Balla G, and Balla J. Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol 20: 1254-1263, 2009.
66. Zarjou A, Kim J, Traylor AM, Sanders PW, Balla J, Agarwal A, and Curtis LM. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. Am J Physiol Renal Physiol 300: F254-F262, 2011.
67. Zhou BO, Yue R, Murphy MM, Peyer JG, and Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15: 154-168, 2014.
68. Zhou H, Ramiya VK, and Visner GA. Bone marrow stem cells as a vehicle for delivery of heme oxygenase-1 gene. Stem Cells Dev 15: 79-86, 2006.
69. Zhu H, Guo ZK, Jiang XX, Li H, Wang XY, Yao HY, Zhang Y, and Mao N. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 5: 550-560, 2010.